• Molecular NameNeomycin
  • SynonymCaswell No; 595; Neomycin B Sulfate; Neomycin Sulfate; Neomycin Sulphate; Neomycin trisulfate salt hydrate; USAF CB-19
  • Weight628.677
  • Drugbank_IDDB00994
  • ACS_NO1404-04-2
  • Show 3D model
  • LogP (experiment)N/A
  • LogP (predicted, AB/LogP v2.0)-10.2
  • pkaN/A
  • LogD (pH=7, predicted)-15.64
  • Solubility (experiment)15 mg/ml
  • LogS (predicted, ACD/Labs)(ph=7)0.2
  • LogSw (predicted, AB/LogsW2.0)387.11
  • Sw (mg/ml) (predicted, ACD/Labs)1000.0
  • No.of HBond Donors19
  • No.of HBond Acceptors19
  • No.of Rotatable Bonds10
  • TPSA353.11
  • StatusFDA approved
  • AdministrationTopical, Oral
  • PharmacologyAn aminoglycoside antibiotic that is found in many topical medications such as creams, ointments and eyedrops.
  • Absorption_value3.0
  • Absorption (description)N/A
  • Caco_2N/A
  • Bioavailability3.0
  • Protein bindingN/A
  • Volume of distribution (VD)N/A
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmN/A
  • Half life2~3 h
  • ExcretionN/A
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicityN/A
  • LD50 (rat)N/A
  • LD50 (mouse)N/A